Hiran Orgochem Ltd
Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations.
- Market Cap ₹ Cr.
- Current Price ₹ 0.48
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -6.23
- Dividend Yield 0.00 %
- ROCE -26.1 %
- ROE %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- The company has delivered a poor sales growth of -70.9% over past five years.
- Company has high debtors of 322 days.
- Working capital days have increased from 1,638 days to 2,355 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 15m | Jun 2012 | Jun 2013 9m | Mar 2014 | Mar 2015 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
112.71 | 107.88 | 119.41 | 188.39 | 202.75 | 147.74 | 38.91 | 23.96 | 2.62 | 0.42 | 0.00 | |
88.58 | 100.23 | 107.70 | 203.12 | 189.89 | 214.97 | 50.99 | 82.59 | 9.08 | 8.32 | -0.05 | |
Operating Profit | 24.13 | 7.65 | 11.71 | -14.73 | 12.86 | -67.23 | -12.08 | -58.63 | -6.46 | -7.90 | 0.05 |
OPM % | 21.41% | 7.09% | 9.81% | -7.82% | 6.34% | -45.51% | -31.05% | -244.70% | -246.56% | -1,880.95% | |
1.08 | 1.83 | 2.67 | 1.62 | 9.07 | 2.81 | 7.64 | 1.47 | 0.93 | -19.79 | 0.93 | |
Interest | 3.62 | 5.18 | 7.57 | 9.99 | 9.09 | 15.22 | 1.90 | 0.08 | 0.18 | 0.01 | 0.06 |
Depreciation | 1.26 | 1.62 | 1.83 | 2.12 | 2.33 | 3.20 | 2.76 | 2.77 | 1.51 | 0.05 | 0.06 |
Profit before tax | 20.33 | 2.68 | 4.98 | -25.22 | 10.51 | -82.84 | -9.10 | -60.01 | -7.22 | -27.75 | 0.86 |
Tax % | 34.19% | 59.70% | 22.09% | -31.09% | 29.12% | 0.65% | 0.00% | 0.00% | 0.00% | 0.00% | |
13.38 | 1.08 | 3.88 | -17.38 | 7.45 | -83.38 | -9.09 | -60.01 | -7.22 | -27.76 | 0.85 | |
EPS in Rs | 3.47 | 0.21 | 0.74 | -3.31 | 1.42 | -8.45 | -0.92 | -6.08 | -0.73 | -2.81 | 0.08 |
Dividend Payout % | 8.65% | 48.61% | 13.53% | -1.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -71% |
3 Years: | -86% |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 24% |
TTM: | 103% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7.72 | 10.50 | 10.50 | 10.50 | 52.50 | 98.66 | 98.66 | 98.66 | 98.66 | 98.66 |
Reserves | 39.34 | 73.69 | 76.96 | 61.00 | 26.44 | -56.94 | -66.03 | -126.04 | -133.26 | -161.02 |
32.75 | 47.89 | 56.67 | 51.62 | 53.70 | 96.15 | 89.05 | 88.76 | 85.71 | 65.45 | |
39.81 | 44.35 | 57.50 | 65.66 | 89.66 | 55.67 | 30.87 | 25.48 | 24.50 | 22.41 | |
Total Liabilities | 119.62 | 176.43 | 201.63 | 188.78 | 222.30 | 193.54 | 152.55 | 86.86 | 75.61 | 25.50 |
27.56 | 31.68 | 35.95 | 36.53 | 37.04 | 38.78 | 35.58 | 33.08 | 31.57 | 0.20 | |
CWIP | 1.22 | 0.57 | 2.27 | 1.26 | 0.14 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 |
Investments | 1.52 | 0.78 | 0.89 | 2.90 | 4.80 | 4.69 | 4.69 | 4.59 | 4.59 | 0.00 |
89.32 | 143.40 | 162.52 | 148.09 | 180.32 | 150.03 | 112.24 | 49.15 | 39.45 | 25.30 | |
Total Assets | 119.62 | 176.43 | 201.63 | 188.78 | 222.30 | 193.54 | 152.55 | 86.86 | 75.61 | 25.50 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
-17.59 | -41.00 | 4.58 | 20.73 | 11.90 | -56.67 | 9.59 | -28.64 | -0.92 | -16.08 | |
-9.00 | -3.24 | -6.58 | -2.60 | -1.29 | -1.10 | 2.28 | 1.11 | 0.96 | 16.13 | |
27.23 | 45.84 | 1.87 | -15.32 | -8.97 | 73.97 | -9.01 | -0.34 | 0.00 | 0.00 | |
Net Cash Flow | 0.64 | 1.60 | -0.13 | 2.81 | 1.64 | 16.20 | 2.86 | -27.87 | 0.04 | 0.05 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 63.67 | 58.46 | 89.01 | 34.31 | 74.58 | 73.47 | 186.21 | 118.67 | 1,159.08 | 321.55 |
Inventory Days | 205.43 | 260.28 | 262.28 | 105.11 | 146.58 | 23.77 | 39.69 | 17.12 | 153.76 | 929.88 |
Days Payable | 132.88 | 130.68 | 189.09 | 124.09 | 160.85 | 89.83 | 266.31 | 350.12 | 3,211.71 | 17,598.21 |
Cash Conversion Cycle | 136.22 | 188.06 | 162.20 | 15.34 | 60.32 | 7.42 | -40.42 | -214.33 | -1,898.87 | -16,346.79 |
Working Capital Days | 158.78 | 331.23 | 319.39 | 138.01 | 145.03 | 169.97 | 498.20 | 358.75 | 2,061.83 | 2,355.12 |
ROCE % | 7.34% | 9.09% | -11.37% | 15.48% | -49.65% | -5.31% | -65.43% | -8.16% | -26.09% |
Documents
Announcements
-
Disclosure under Reg. 30 of SEBI (LODR) Regulations, 2015
31 Aug 2016 - Hiran Orgochem Ltd has informed BSE regarding Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.
- Limited Review Report for June 30, 2016 12 Aug 2016
- Outcome of Board Meeting 11 Aug 2016
- Fixes Book Closure for AGM (Cut-off date for e-voting) 11 Aug 2016
- Standalone & Consolidated Financial Results, Limited Review Report for June 30, 2016 11 Aug 2016